Versant Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Versant Capital Management’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.21K	Buy	+61	New	+$1.79K	﹤0.01%	2552

Other funds holding ETON

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Versant Capital Management's ETON Position: Q2 2026 in Review

Versant Capital Management opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 61 shares worth $2.21K. The stake represents ﹤0.01% of the portfolio and ranks #2552 among its holdings.

165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

Versant Capital Management held 61 shares of Eton Pharmaceutcials worth $2.21K as of Q2 2026.
Eton Pharmaceutcials was a new Versant Capital Management position in Q2 2026.
Eton Pharmaceutcials made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2552 holding.
165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.